NEW YORK, NY / ACCESSWIRE / November 15, 2017 / U.S. markets fell Tuesday on slumping commodity prices, with U.S. crude oil posting its largest one day drop in over a month. The Dow Jones Industrial Average declined 0.13 percent to close at 23,409.47, while the S&P 500 Index fell 0.23 percent to close at 2,578.87. The Nasdaq Composite Index dropped 0.29 percent to close at 6,737.87. On Tuesday, the International Energy Agency said the recent rally in crude oil prices could be short-lived and global demand will be weaker-than-expected for the rest of the year and next.
"Since Friday, the theme has been deleveraging and taking risk off the table," said Larry Peruzzi, managing director of international equity trading at Mischler Financial, according to The Wall Street Journal. "Part of it has been profit-taking and part of it has been uncertainty with taxes and Washington."
RDI Initiates Coverage on:
Array BioPharma Inc.
Array BioPharma Inc.'s stock moved 1.60% lower Tuesday, to close the day at $10.44. The stock recorded a trading volume of 3,444,551 shares, which was below its three months average volume of 4,193,141 shares. In the last year, Array BioPharma Inc.'s shares have traded in a range of 6.72 - 13.40. The share price has gained 55.36% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $11.48 is greater than its 200-day moving average of $9.37. Shares of Array BioPharma have fallen roughly 15.53 percent in the past month and are up 18.77 percent year-to-date.
Access RDI's Array BioPharma Inc. Research Report at:
On Tuesday, shares in Intrexon Corporation recorded a trading volume of 2,820,710 shares, which was above the three months average volume of 1,170,264 shares. The stock ended the day 0.79% higher at 12.68. The share price has gained 23.59% from its 52-week low with a 52-week trading range of 10.26 - 32.90.The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $17.43 is below its 200-day moving average of $20.52. Shares of Intrexon have fallen roughly 29.52 percent in the past month and are down 47.82 percent year-to-date.
Access RDI's Intrexon Corporation Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.